3D Systems Receives FDA Clearance for NextDent® Base
November 15 2023 - 8:30AM
Today, 3D Systems (NYSE:DDD) announced the Food and Drug
Administration (FDA) has provided 510(k) clearance for its
NextDent Base material that is intended for the manufacturing of
denture bases to support artificial teeth to form full or partial
removable dentures. This material is approved by Health Canada and
also received CE marking 1639. NextDent Base is the third
generation of the company’s denture base material for 3D printing
and has excellent mechanical properties including high break
resistance, and accurate and repeatable printability. NextDent Base
is truly comparable to conventional denture materials and provides
patients with long-lasting, impact-resistant dentures.
Additionally, the material is available in four colors to match the
most popular gingiva shades for improved aesthetics. Using NextDent
Base as part of 3D Systems’ digital dental workflow is helping
drive new levels of speed, productivity, efficiency, and precision
while also providing opportunities to improve the patient
experience.
NextDent Base is already receiving positive
feedback in the market. Steven Campbell, RDT FCGDent, with Nexus
Dental Laboratory (Harrogate, United Kingdom) has been running
trial tests with the material and stated, “This new material is
truly amazing! No support bar across the heels, lovely delicate
supports which are easy to remove, and the fit of the teeth to
denture and denture to bar show just how stable this is. We have
just started trials with it, but already I can see the strength of
this is going to make it an incredible material to keep an eye on.
We are so confident in the strength we see on early prints that we
are going to run some test partials with it.”
Additionally, Dr. Kunal Lal, DDS, MS, Board
Certified Prosthodontist, at LAL Dental (New York, New York) said,
“I really enjoyed testing the NextDent Base material. It is pink,
flexible in thinner sections, and can be used for same-day interim
RPD fabrication. Some of the other properties worth noting are
minimal mixing, cleaning of residual material on the surface
is easier, and improved strength.”
The adoption of 3D printing to produce
prosthodontics continues to accelerate, yet there is still
significant opportunity. According to 360 Research Reports, the
global 3D Printed Dentures market size was estimated to be more
than $1 billion in 2021 and is forecast to reach more than $2
billion by 2028. The use of digital workflows such as 3D Systems’
digital dentistry solution comprising its NextDent Base material,
along with its NextDent 3D printing technology with a trusted
connection with industry-leading software packages, results in a
complete workflow including post-processing to ensure the best
possible product. With 3D Systems’ NextDent solution, dental
laboratories and clinics are now able to produce dental devices at
dramatically increased speed while reducing material waste and
capital equipment expenditure as well as reliance upon milling
centers. Benefits also extend to the patient by reducing the time
it takes to produce prosthodontics, as well as the number of
required office visits.
“Our goal is to ensure we are addressing our
customers’ needs with our solutions, and this is yet another step
in achieving that goal,” said Chuck Stapleton, vice president and
general manager, dental, 3D Systems. “With the clearance of
NextDent Base, we continue to add to our portfolio of dental 3D
printing materials that are enabling dental laboratories and
clinics to address a wide range of applications. These offerings
are helping our customers accelerate the adoption of additive
manufacturing as part of their workflows and drive new levels of
speed, productivity, efficiency, and precision while also providing
opportunities to improve the patient experience.”
NextDent Base is the latest addition to 3D Systems’
portfolio of 30 unique NextDent resins – the largest number
available from any dental 3D printing material supplier. The
material is available in four colors to match a variety of
aesthetics and is available for immediate ordering.
NextDent 3D printing materials for medical devices
are biocompatible and CE-certified in accordance with Medical
Device Directive 93/42/EEC, listed at the FDA, and registered in
various other countries. The complete NextDent portfolio – for both
medical and non-medical devices – is suitable for a wide range of
3D-printed dental applications. For more information, please visit
the company’s website.
Forward-Looking StatementsCertain statements
made in this release that are not statements of historical or
current facts are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to be materially
different from historical results or from any future results or
projections expressed or implied by such forward-looking
statements. In many cases, forward-looking statements can be
identified by terms such as "believes," "belief," "expects," "may,"
"will," "estimates," "intends," "anticipates" or "plans" or the
negative of these terms or other comparable terminology.
Forward-looking statements are based upon management’s beliefs,
assumptions, and current expectations and may include comments as
to the company’s beliefs and expectations as to future events and
trends affecting its business and are necessarily subject to
uncertainties, many of which are outside the control of the
company. The factors described under the headings "Forward-Looking
Statements" and "Risk Factors" in the company’s periodic filings
with the Securities and Exchange Commission, as well as other
factors, could cause actual results to differ materially from those
reflected or predicted in forward-looking statements. Although
management believes that the expectations reflected in the
forward-looking statements are reasonable, forward-looking
statements are not, and should not be relied upon as a guarantee of
future performance or results, nor will they necessarily prove to
be accurate indications of the times at which such performance or
results will be achieved. The forward-looking statements included
are made only as of the date of the statement. 3D Systems
undertakes no obligation to update or review any forward-looking
statements made by management or on its behalf, whether as a result
of future developments, subsequent events or circumstances or
otherwise, except as required by law.
About 3D Systems More than 35 years ago, 3D
Systems brought the innovation of 3D printing to the manufacturing
industry. Today, as the leading additive manufacturing solutions
partner, we bring innovation, performance, and reliability to every
interaction - empowering our customers to create products and
business models never before possible. Thanks to our unique
offering of hardware, software, materials, and services, each
application-specific solution is powered by the expertise of our
application engineers who collaborate with customers to transform
how they deliver their products and services. 3D Systems’ solutions
address a variety of advanced applications in healthcare and
industrial markets such as medical and dental, aerospace &
defense, automotive, and durable goods. More information on the
company is available at www.3dsystems.com.
Investor
Contact: |
|
investor.relations@3dsystems.com |
Media Contact: |
|
press@3dsystems.com |
3D Systems (NYSE:DDD)
Historical Stock Chart
From Mar 2024 to Apr 2024
3D Systems (NYSE:DDD)
Historical Stock Chart
From Apr 2023 to Apr 2024